IMR Press / CEOG / Volume 46 / Issue 2 / DOI: 10.12891/ceog4518.2019

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Tspan5 inhibits proliferation and migration of JEG-3 cells by inhibiting FAK and AKT phosphorylation
X. Ren1,*,†H-Y. Tang2,†J. Wu1T-Y. Gao1,†J. Li1
Show Less
1 Department of Reproductive Medicine, Guangdong No.2 Provincial People’s Hospital, Guangzhou, China;
2 Department of Reproductive Medicine, Meizhou People's Hospital, Meizhou, Guangdong, China
*Correspondence: (XIN REN)
Contributed equally.
Clin. Exp. Obstet. Gynecol. 2019, 46(2), 280–284;
Published: 10 April 2019

Objectives: To study the effect of Tspan5 on the proliferation and migration of trophoblast cells. Materials and Methods: The authors silenced the Tspan5 expression in human choriocarcinoma cell line JEG-3 using RNAi, and then conducted the cell proliferation assay and scratch assay to detect the proliferation and migration of JEG-3 cells. Results: The present authors found that the JEG-3 cell proliferation and migration activity of interference group (Tspan5/1005) had decreased significantly. Tspan5/1005 moderately decreased FAK and AKT phosphorylation compared to the control group. In this study, the authors found that the proliferation and migration of choriocarcinoma cells were reduced after using RNAi technology to downregulate the expression level of Tspan5 expression. The level of Tspan5 expression was positively correlated with the proliferation and migration of choriocarcinoma cells. Conclusions: Tspan5 could play a biological role through the FAK/AKT signaling pathway.

Human choriocarcinoma cell line JEG-3
Figure 1.
Back to top